Article Information
History
- July 24, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Evangeline Obodai, PhD1,†,*,
- Jonne Terstappen, MD2,3,†,
- Jude Y. Mensah, BSc1,
- Anouk Versnel, MSc3,
- Comfort N. Antwi, MPhil1,
- Louis J. Bont, PhD2,4,
- Daniela Cianci, PhD5,
- Eveline M. Delemarre, PhD3,
- John K. Odoom, PhD1,
- Peter M. van de Ven, PhD5 and
- Natalie I. Mazur, PhD2,3,*
- 1Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana
- 2Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
- 3Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
- 4ReSViNET Foundation, Zeist, The Netherlands
- 5Julius Center for Health Sciences and Primary Care, Department of Data Science & Biostatistics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- ↵*Corresponding authors:
1. Dr Natalie I Mazur, Email: n.i.mazur{at}umcutrecht.nl, 2. Dr Evangeline Obodai, Email: eobodai{at}noguchi.ug.edu.gh
↵† Dr. E. Obodai and Drs. J. Terstappen contributed equally to this article.
Posted July 24, 2024.
Technology transfer of a dried blood virus neutralization assay to a GAVI-eligible country
